Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Westerweel

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 15, 2023
Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort studyCamiel L M de Roij van Zuijdewijn, Peter E Westerweel, Martin R Schipperus, et al.
Leukemia & Lymphoma|April 5, 2018
Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapyLina van der Straten, Avinash G Dinmohamed, Peter E Westerweel, et al.
Haematologica|March 31, 2022
The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor eraCamille C B Kockerols, Inge Geelen, Mark-David Levin, et al.
American Journal of Physiology. Renal Physiology|January 4, 2007
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cellsPeter E Westerweel, Imo E Hoefer, Peter J Blankestijn, et al.
Leukemia|May 11, 2018
Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patientsInge G P Geelen, Fredrik Sandin, Noortje Thielen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Progenitor cells and vascular function are impaired in patients with chronic kidney diseaseKim E Jie, Masha A Zaikova, Marloes W T Bergevoet, et al.
Leukemia & Lymphoma|November 12, 2022
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The NetherlandsGeneviève I C G Ector, Inge G P Geelen, Avinash G Dinmohamed, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2017
Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatmentHánah N Rier, Agnes Jager, Marieke C Meinardi, et al.
Leukemia|February 19, 2021
Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the NetherlandsGeneviève I C G Ector, Otto Visser, Eduardus F M Posthuma, et al.
Blood Cancer Journal|January 6, 2025
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patientsPaul J Hengeveld, Joyce Schilperoord-Vermeulen, P Martijn Kolijn, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 15, 2023
Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort studyCamiel L M de Roij van Zuijdewijn, Peter E Westerweel, Martin R Schipperus, et al.
Leukemia & Lymphoma|April 5, 2018
Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapyLina van der Straten, Avinash G Dinmohamed, Peter E Westerweel, et al.
Haematologica|March 31, 2022
The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor eraCamille C B Kockerols, Inge Geelen, Mark-David Levin, et al.
American Journal of Physiology. Renal Physiology|January 4, 2007
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cellsPeter E Westerweel, Imo E Hoefer, Peter J Blankestijn, et al.
Leukemia|May 11, 2018
Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patientsInge G P Geelen, Fredrik Sandin, Noortje Thielen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Progenitor cells and vascular function are impaired in patients with chronic kidney diseaseKim E Jie, Masha A Zaikova, Marloes W T Bergevoet, et al.
Leukemia & Lymphoma|November 12, 2022
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The NetherlandsGeneviève I C G Ector, Inge G P Geelen, Avinash G Dinmohamed, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2017
Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatmentHánah N Rier, Agnes Jager, Marieke C Meinardi, et al.
Leukemia|February 19, 2021
Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the NetherlandsGeneviève I C G Ector, Otto Visser, Eduardus F M Posthuma, et al.
Blood Cancer Journal|January 6, 2025
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patientsPaul J Hengeveld, Joyce Schilperoord-Vermeulen, P Martijn Kolijn, et al.
Pageof 11